Biotechnology etf plunges! Pharmaceutical stocks collectively decline, with the United States Secretary of Health and Human Services nominee raising market concerns.

Breakings · 00:16

U.S. biotechnology ETF tumbles! Leveraged 3x biotechnology ETF drops over 14%, SPDR S&P Biotech ETF, biotechnology index ETF drop over 4%; pharmaceutical stocks collectively decline, with Eli Lilly falling over 4%, Novo-Nordisk, Pfizer dropping nearly 4%, AstraZeneca, Gilead Sciences down over 2%.

In the news, Trump stated that he would appoint Robert F. Kennedy Jr. as the Secretary of the USA Department of Health and Human Services (HHS). Trump's move could elevate a well-known "vaccine skeptic" and broader industry critic to the highest position in USA medical health and health policy, raising concerns in the market about the medical industry.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

生物科技ETF遭重挫！医药股集体下行，美国卫生部长提名人引市场担忧

Biotechnology etf plunges! Pharmaceutical stocks collectively decline, with the United States Secretary of Health and Human Services nominee raising market concerns.

Risk Disclaimer

Statement